0      0


EFFECT OF AVACOPAN, A SELECTIVE C5A RECEPTOR INHIBITOR, ON KIDNEY FUNCTION IN PATIENTS WITH ANCA-ASSOCIATED VASCULITIS


‐ Mar 20, 2022 11:00am


Speaker(s):

You must be logged in and own this session in order to post comments.